Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00151736 · TERMINATED
Trial details
- NCT number
- NCT00151736
- Sponsor
- Cephalon
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2006-02-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.